Page 61 of 66
The aim is to deepen our understanding of headache by three approaches. First, by trying to feel patients’ total experience by eliciting their symptoms in detail, and from their reactions to these experiences....
The following is the case of a 55-year-old woman showing palpebral ecchymoses ipsilateral to the symptomatic side during migraine episodes. The lesions are not associated with oedema or other vegetative manife...
The objective was to assess the effect of botulinum toxin type-A (BTX-A) in treating chronic tension-type headache (CTTH). A single centre, open label, pilot study was carried out at the Headache and Pain Cent...
The objective was to identify a subset of preferred triptans from among available agents. A criterion of dominance was applied to statistically significant differences which emerged from a recent meta-analysis...
Septoplasty is one of the most common nasal operations performed in otorhinolaryngological practice. At the end of the operation, most surgeons place nasal packings and remove them after 48–72 hours. The remov...
The objectives were to compare patient preference for zolmitriptan nasal spray with their current acute therapies for migraine (by asking whether or not they wished to continue to use zolmitriptan nasal spray)...
Hangover headache has been focused upon in connection with the Vågå study of headache epidemiology, with 714 cases among 1122 dalesmen (64%). Most frequently the headache was global in location. It was more fr...
As part of the Vågå study of headache epidemiology, the symptomatology of hangover headache has been studied in 1122 parishioners in the age group 18–65 years; male/female ratio 1.14. The following criteria fo...
Pharmacoeconomics, the application of health economics to pharmaceuticals, is an increasingly important part of the evaluation of any therapy. It is a response to limitations on the resources available for med...
With the rapid advances in the treatment of migraine attacks in the last few years, a number of non-specific anti-migraine drugs have been developed for clinical use. The most important class of drugs for the ...
This article is part of a Supplement: Volume 5 Supplement 2
Sleep disorders and headache are frequently comorbid. Anatomical, biochemical and physiologic common features and pathways could explain the bidirectional influence between sleep disorders and headache. One of...
This article is part of a Supplement: Volume 5 Supplement 2
Antidepressants are often used in the prophylaxis of chronic headaches, but their effectiveness is uncertain. A recent meta-analysis showed that antidepressants are effective in the treatment of chronic headac...
This article is part of a Supplement: Volume 5 Supplement 2
The hypothesis that cortical hyperexcitability may play an important role in the physiopathology of migraine has lead to the therapeutic use of antiepileptic drugs in headache prophylaxis. Cortical hyperexcita...
This article is part of a Supplement: Volume 5 Supplement 2
Triptans are the treatment of choice for migraine sufferers with disabling attacks. However, the proportion of patients reporting side effects after any acute treatment may vary in regard to the method of asse...
This article is part of a Supplement: Volume 5 Supplement 2
Despite the pharmacokinetic differences among triptans and the variety of ways of administration, the clinical differences in everyday use of these drugs do not allow a largely accepted decisional tree. There ...
This article is part of a Supplement: Volume 5 Supplement 2
The importance of the neuropsychological aspect in patients affected by tension headache is highlighted by different data in the literature as well as the results of a multicentric Italian study on comorbidity...
This article is part of a Supplement: Volume 5 Supplement 2
Pharmacotherapeutic treatments for migraine have been documented for more than a century. Drugs that are effective in aborting an ongoing migraine attack exhibit a diversity of molecular mechanisms of action, ...
This article is part of a Supplement: Volume 5 Supplement 2
Hemicrania continua was described in 1984 by Sjastaad and Spierings as a unilateral, almost always side-locked headache that is continuous and fluctuating in intensity. There are added pain exacerbation period...
This article is part of a Supplement: Volume 5 Supplement 2
Patients with chronic daily headache (CDH) are difficult to treat. A combination of general measures and specific pharmacological treatments is necessary. When possible, pharmacological management should be pl...
This article is part of a Supplement: Volume 5 Supplement 2
Migraine is a highly prevalent headache disorder that has a substantial impact on the individual and society. Over the past decade, substantial advances in research have increased understanding of the pathophy...
This article is part of a Supplement: Volume 5 Supplement 2
Several studies on patients observed in headache centers show an association between headache, including migraine, and arterial hypertension. As both these pathologies have an elevated prevalence in the genera...
This article is part of a Supplement: Volume 5 Supplement 2
The association between headache, especially migraine, and some immunomediated diseases, in particular autoimmune diseases, is well known. The evidence in favor of this association comes prevailingly from epid...
This article is part of a Supplement: Volume 5 Supplement 2
Migraine and cerebrovascular disease are linked in different ways: migraine may be a potential cause of stroke as in migrainous infarction, headache may be a symptom of cerebrovascular disease and also a risk ...
This article is part of a Supplement: Volume 5 Supplement 2
Placebo and placebo effect are important issues related to the drug therapy for clinical and scientific meanings. The rates of placebo may get as many as 50% for analgesic drugs in headache. The high answer to...
This article is part of a Supplement: Volume 5 Supplement 2
Since it is extremely important to fully evaluate the psychological characteristics of young headache sufferers and their family circle, we have implemented a diagnostic therapeutic protocol arranged in a numb...
This article is part of a Supplement: Volume 5 Supplement 2
Research in the field of headache treatment has experienced a marked impetus in the last few years. In the era of the triptans, the treatment modality of this disease has been revolutionised, and though most o...
This article is part of a Supplement: Volume 5 Supplement 2
Although migraine is a common complaint in childhood and adolescence, there is a lack of controlled clinical studies regarding treatment. In the young patient, the pharmacological approach should be preceded b...
This article is part of a Supplement: Volume 5 Supplement 2
Children frequently suffer from migraine or tension-type headaches, and the headache pain not only interferes with a patient’s life but can affect his entire family. Headache management includes not only pharm...
This article is part of a Supplement: Volume 5 Supplement 2
We reviewed P300 and contingent negative variation (CNV) studies performed in migraine in order to identify their relevance in migraine and the role of neurophysiology in migraine. Publications available to us...
This article is part of a Supplement: Volume 5 Supplement 2
Several studies have investigated brain bioelectrical activity with the aid of electroencephalographic brain mapping in migraine patients examined in the interictal period or during a spontaneous attack. The p...
This article is part of a Supplement: Volume 5 Supplement 2
Headaches can be considered as a paradigm for the so-called “invisible” diseases; difficulties that headache patients encounter and complain from often relate more to the lack of understanding and communicatio...
The objective was to provide objective imaging evidence of functional changes in brainstem structures involved in chronic daily headache (CDH). Over time, episodic migraine (EM) patients may develop CDH known ...
We present a case of cold-induced visual symptoms in a 74-year-old woman with a history of migraine headaches. Migraine without aura was the starting symptom. It coexisted later with a typical pain of ice crea...
We wanted to document Turkish migraine sufferers’ unconventional therapy methods learnt from their social environment and discuss the historical background and possible action mechanisms of these methods. Unco...
The objective was to measure the cost of botulinum toxin type A (BTX-A) treatment of chronic tension-type headache. A prospective pharmaceutical costing analysis was completed in the Day Hospital of the Region...
The objective was to measure the impact of botulinum toxin type A (BTX-A) treatment on symptoms and medication utilisation patterns in patients with chronic tension-type headache. A retrospective chart analysi...
In Vågå, Norway, with 3907 inhabitants, there were 2075 18–65-year-old dalesmen available for the headache epidemiology study. A total of 1838 dalesmen (88.6%) were personally examined. However, due to uncerta...
New imaging technology allows us to study neurologic disorders that have had no previous structural basis. There have been recent reports on the involvement of nociceptive pathways in daily headache. A systema...
The objective was to examine the main genetic and environmental architecture of migraine in the Screening Across Lifetime of Twin (SALT) Study as a function of definition. We performed a quantitative genetic s...
A pair of identical twins with cluster headache is described. Monozygosity was confirmed by the identification of 14 DNA markers. In spite of harboring the same genes, the clinical picture presented by the twi...
We applied the second edition of the International Classification of Headache Disorders (ICHD-II) in 417 children (age range, 2–12 years) with chronic headaches attending a pediatric headache clinic. The initi...
Cluster headache (CH) is one of the most painful primitive headaches that exists. Since 1991, the subcutaneous administration of sumatriptan (SCS) in the treatment of acute attacks has proved to be rapid and e...
The Journal of Headache and Pain is the official journal of the European Headache Federation and Lifting The Burden.
2022 Citation Impact
7.4 - 2-year Impact Factor
7.1 - 5-year Impact Factor
2.002 - SNIP (Source Normalized Impact per Paper)
1.593 - SJR (SCImago Journal Rank)
2023 Speed
3 days submission to first editorial decision for all manuscripts (Median)
44 days submission to accept (Median)
2023 Usage
3,022,321 downloads
3,296 Altmetric mentions